- GST NO. : 24ABRCS0973R1ZE
- Send Email
| Business Type | Manufacturer, Supplier |
| Packaging Type | Box,Bag & Drum |
| Usage | Chemical Synthesis, Pharmaceutical Intermediate |
| Material | Chemical Compound |
| Click to view more | |
Product Details
DFTA is a high-purity intermediate essential for the synthesis of Letrozole, a key drug used in hormone-responsive breast cancer treatment. Its stable structure ensures reliable performance in large-scale API production, making it a trusted choice in oncology-related pharmaceutical manufacturing.
Product Highlights-
High-Purity Intermediate: Ensures reliable pharmaceutical outcomes
-
Critical for Oncology: Essential for hormone-responsive breast cancer drugs
-
Stable Structure: Suitable for large-scale API production
-
Trusted in Pharma: Widely used in oncology-related formulations
-
Reliable Performance: Consistent results in pharmaceutical manufacturing
-
Pharmaceutical Intermediate: Key intermediate in the synthesis of Letrozole
-
Oncology Applications: Used in the production of hormone therapy drugs for breast cancer treatment
-
Store in a cool, dry environment away from direct light
-
Avoid inhalation, ingestion, and prolonged skin contact
-
Use protective clothing, gloves, and safety goggles during handling
-
Dispose of waste according to pharmaceutical regulations
